In our study, we are the first to reveal that targeting KCNJ11/ABCC8 for diabetes treatment could reduce the incidence of PT from a genetic perspective, with gene expression analysis further supporting the role of KCNJ11 in PT. This evidence concerns the gene KCNJ11 and diabetes mellitus.